These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25132681)

  • 1. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
    Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
    Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate.
    Kataria Y; Wright M; Deaton RJ; Rueter EE; Rybicki BA; Moser AB; Ananthanrayanan V; Gann PH
    Prostate; 2015 Feb; 75(2):200-10. PubMed ID: 25307752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study.
    Wright ME; Bowen P; Virtamo J; Albanes D; Gann PH
    Int J Cancer; 2012 Sep; 131(6):1396-406. PubMed ID: 22120496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
    Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
    J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.
    Price AJ; Allen NE; Appleby PN; Crowe FL; Jenab M; Rinaldi S; Slimani N; Kaaks R; Rohrmann S; Boeing H; Pischon T; Benetou V; Naska A; Trichopoulou A; Palli D; Sieri S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Donate I; González CA; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Khaw KT; Rodwell S; Gallo V; Michaud DS; Riboli E; Key TJ
    Am J Clin Nutr; 2010 Jun; 91(6):1769-76. PubMed ID: 20427733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of phytanic acid are associated with prostate cancer risk.
    Xu J; Thornburg T; Turner AR; Vitolins M; Case D; Shadle J; Hinson L; Sun J; Liu W; Chang B; Adams TS; Zheng SL; Torti FM
    Prostate; 2005 May; 63(3):209-14. PubMed ID: 15712232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
    Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of phytanic acid and pristanic acid in man: a review.
    Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
    J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids.
    Allen NE; Grace PB; Ginn A; Travis RC; Roddam AW; Appleby PN; Key T
    Br J Nutr; 2008 Mar; 99(3):653-9. PubMed ID: 17868488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
    ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
    J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
    ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
    Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry.
    Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):281-7. PubMed ID: 9746242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
    Kruska N; Reiser G
    Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
    Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
    Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasma pristanic, phytanic and very long chain fatty acids by liquid chromatography-electrospray tandem mass spectrometry for the diagnosis of peroxisomal disorders.
    Johnson DW; Trinh MU; Oe T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):159-62. PubMed ID: 14630371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytanic acid--an overlooked bioactive fatty acid in dairy fat?
    Hellgren LI
    Ann N Y Acad Sci; 2010 Mar; 1190():42-9. PubMed ID: 20388135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
    ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
    J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of phytanic acid are associated with prostate cancer risk.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824. PubMed ID: 16217297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.